<DOC>
	<DOC>NCT00318344</DOC>
	<brief_summary>For thousands of years people in the South Pacific have used Atuna racemosa extract as a topical anti-inflammatory. We, the researchers at the Mayo Clinic, have shown this extract to also have antibacterial properties. While this extract has been used for decades in the South Pacific, a controlled clinical trial to evaluate toxicity has never been performed.</brief_summary>
	<brief_title>Evaluation of Atuna Racemosa Toxicity</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<criteria>The subjects will be 20 healthy male and nonpregnant, nonlactating, female volunteers of ages 18 65. No subject will be excluded based on minority status.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>